Ara
Toplam kayıt 126, listelenen: 41-50
COVID-19 clinical course and blood groups: Turkish population-based study
(Tubitak Scientific & Technical Research Council Turkey, 2021)
Background/aim: SARS-CoV-2 enters the cell through the binding of the S glycoprotein on the surface of the virus to the angiotensin-converting enzyme 2 (ACE-2) in the host cells and also SARS-CoV S protein binding to ACE-2 ...
Convalescent plasma therapy in patients with COVID-19
(Pergamon-Elsevier Science Ltd, 2021)
Introduction: Passive antibody therapy has been used to immunize vulnerable people against infectious agents. In this study, we aim to investigate the efficacy of convalescent plasma (CP) in the treatment of severe and ...
Psoriasis Symptom Inventory (PSI) as a patient-reported outcome in mild psoriasis: Real life data from a large psoriatic arthritis registry
(Aves, 2020)
Objective: Our aim is to test the validity of the Psoriasis Symptom Inventory (PSI), a patient-reported outcome, to assess the psoriasis severity within the scope of rheumatology. Methods: Within the PsA international ...
Tyrosine kinase inhibitors and COVID-19
(Sage Publications Ltd, 2020)
[No Abstract Available]
Biological and targeted-synthetic disease-modifying antirheumatic drugs with concomitant methotrexate or leflunomide in rheumatoid arthritis: Real-life TReasure prospective data
(Clinical and Experimental Rheumatology S.A.S., 2021)
Objective To determine the real-life efficacy, safety, and drug-retention rates of leflunomide (LEF) or methotrexate (MTX) as a synthetic DMARD used in combination with biological DMARDs for rheumatoid arthritis (RA). ...
Prognostic values of various hematological variables as markers of systemic inflammation in metastatic lung cancer
(Wolters Kluwer Medknow Publications, 2020)
Background: Chronic state of inflammation is an important factor in advanced cancer which is used by tumor cells for maintaining survival and growth. Hematological parameters such as neutrophil/lymphocyte ratio (NLR), ...
Convalescent plasma therapy in patients with COVID-19 (Letter)
(Pergamon-Elsevier Science Ltd, 2021)
[No Abstract Available]
Convalescent plasma therapy in patients with COVID-19
(Wiley, 2020)
There are currently no licensed vaccines or therapeutics for COVID-19. Anti-SARS CoV-2 antibody-containing plasmas, obtained from the recovered individuals who had confirmed COVID-19, have been started to be collected using ...
Evaluation of Asymptomatic Bacteriuria and Urinary Tract Infection in Patients With Primary Sjögren's Syndrome
(Turkish League Against Rheumatism, 2020)
Objectives: This study aims to determine the frequency and risk factors of bacteriuria and urinary tract infection (UTI) in patients with primary Sjogren's syndrome (SS) and their differences from healthy individuals and ...
A Case of Acute Cholestatic Hepatitis Due to Epstein-Barr Virus Infection
(Aves, 2020)
Hepatic involvement during the Epstein-Barr virus (EBV) infection is frequently seen. Elevated liver enzymes occur usually from mild to moderate. However, acute cholestatic hepatitis is a rare complication. Herein, we ...